Los Angeles County has recorded its first confirmed fatal overdose linked to cychlorphine, a synthetic opioid so potent that laboratory testing suggests it is roughly ten times stronger than fentanyl. The death occurred in February, according to the Los Angeles County Department of Public Health, which said the county medical examiner's office identified cychlorphine as a cause of death — marking the first confirmed presence of the drug in the county's illicit drug supply.
The finding, first reported by MyNewsLA.com, arrives as county health officials warn residents about the drug, also known as n-propionitrile chlorphine. Officials say cychlorphine can cause severe respiratory depression and death, and exposure to even a small amount can cause a person to stop breathing. Compounding the danger, standard fentanyl test strips cannot detect the substance, meaning it can be mixed into other illicit drugs without users ever knowing.
A Potency Rooted in 1960s Chemistry
Cychlorphine belongs to the piperidine benzimidazolone class of opioids — informally called the “orphine” subclass — built on chemical structures first explored in 1960s pharmaceutical research, according to in vitro testing by the Center for Forensic Science Research and Education. The center's research also reports potency data for the drug.
The drug was first detected in the U.S. illicit drug supply in 2024 and has since been identified in 19 states, per the health department. It has turned up in powders, counterfeit prescription pills, rocks or crystals, and liquids. Combining cychlorphine or other opioids with alcohol, sedatives, painkillers or other drugs heightens the risk of death, officials said.
Federal Scheduling and a Global Supply Shift
The U.S. Drug Enforcement Administration classified cychlorphine as a Schedule I controlled substance in August 2026, making it illegal to possess or sell; the Food and Drug Administration has not approved it for any medical use. A July notice of intent preceded the classification.
A CFSRE analysis reported that orphine analogue positivity increased after China imposed generic scheduling controls on nitazene opioids in July 2025, while nitazene analogue positivity declined.
Another Northern California Death, and a Nationwide Pattern
LA County's case is not the state's first. Another cychlorphine-caused death was reported in Northern California in April, per the county health department. A 16-year-old in San Francisco died that month from an overdose involving the drug — Northern California's first confirmed cychlorphine fatality — which led to a September arrest of four pill suppliers after San Francisco police seized more than 20,000 counterfeit prescription pills, Hoodline previously reported.
Nationally, White House Office of National Drug Control Policy data reported by May 2026 counted at least 55 cychlorphine-linked deaths, with the heaviest concentration in Tennessee, Ohio and Texas. The largest single regional cluster emerged in East Tennessee, where local forensic officials confirmed the drug in at least 41 overdose deaths between July 2025 and February 2026, after the Knox County Regional Forensic Center first identified it in Tennessee in a case from late November 2025.
A Decline in Overdoses, With a New Threat Emerging
Cychlorphine's arrival in LA County comes during a period of improving overdose trends. Overall drug overdose deaths in Los Angeles County fell 6% in 2025 to 2,298 fatalities, according to the Los Angeles Times. Fentanyl-related deaths declined 40% from 2022 to 2025, while methamphetamine became the leading driver of overdose deaths in 2025. Accidental overdose deaths in the county had peaked in 2022 at 3,220 before entering a three-year decline, the paper reported.
Federal prosecutors have not slowed their pursuit of fatal overdose cases in the region. The DEA's Los Angeles Field Division OD Justice Task Force filed federal distribution charges resulting in death in 20 cases in 2025 alone, part of a broader effort in which prosecutors have charged more than 160 defendants in fatal overdose poisonings in the Central District of California since 2018, Hoodline has reported.
Detection Gaps Worry Clinicians
Diagnosing a cychlorphine overdose in real time remains difficult. The drug may not appear on standard hospital urine drug screens or routine test strips, so clinicians should treat overdose symptoms immediately rather than waiting for lab confirmation.
What LA County Residents Should Do
LA County health officials are monitoring the local illicit drug supply for signs of increased cychlorphine circulation and are advising residents to avoid illicit substances altogether, since cychlorphine may be present without a user's knowledge. Residents are urged to carry naloxone, the overdose-reversal medication, which can restore breathing in someone experiencing an opioid overdose, including one involving cychlorphine — though it may require multiple doses to work. Naloxone is available as a nasal spray or an injection through county community health stations, public health centers, retail pharmacies and medical providers.
Anyone responding to a suspected overdose should immediately call 911 and administer naloxone. Drug samples can be tested for cychlorphine through a free drug-checking program at drugcheckingla.com, which delivers results in approximately 15 to 20 minutes. Residents seeking substance use disorder treatment can find services through sudhelpla.org and recoverla.org, and the Los Angeles County Substance Abuse Service Helpline can be reached at 800-854-7771; Poison Control is available at 800-222-1222.
